|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06667 MEGA GENOMICS
Nominal 
7.390 +0.150 (+2.072%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 164,226 | 151,300 | 145,727 | 237,185 |
| Cost of Sales | -- | -- | (44,878) | (63,004) | (64,004) | (70,509) |
| Gross Profit | -- | -- | 119,348 | 88,296 | 81,723 | 166,676 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | 7,294 | 11,579 | (25,852) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (15,516) | (20,167) | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | 53,633 | 36,179 | (21,418) | 95,882 | |
| Taxation | -- | -- | (8,588) | (6,141) | 3,800 | (16,867) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 27,021 | -40.013% | 45,045 | 30,038 | (17,618) | 79,015 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 47 | 400 | (667) | 6,641 |
| Depreciation & Amortisation | -- | -- | 14,674 | 15,120 | 15,278 | 13,873 |
| Directors' Emoluments | -- | -- | -- | 8,623 | 6,594 | 1,166 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 14.000 | -36.364% | 22.000 | 14.000 | -9.000 | 62.000 |
| DPS (cts) | 15.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | 107.143% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | 0.773 | (0.034) | 0.241 |
| NBV per share ($) | -- | -- | 2.649 | 2.709 | 2.583 | -- |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 27,021 |
| %Change | -40.013% |
| EPS / (LPS) | RMB 0.140 |
| NBV Per Share (¥) | RMB -- |